Annual EPS
-$1.06
+$1.54+59.23%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual earnings per share is -$1.06, with the most recent change of +$1.54 (+59.23%) on December 31, 2023.
- During the last 3 years, DNLI annual EPS has fallen by -$1.69 (-268.25%).
- DNLI annual EPS is now -268.25% below its all-time high of $0.63, reached on December 31, 2020.
Performance
DNLI EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.63
-$0.04-6.78%
September 30, 2024
Summary
- As of February 7, 2025, DNLI quarterly earnings per share is -$0.63, with the most recent change of -$0.04 (-6.78%) on September 30, 2024.
- Over the past year, DNLI quarterly EPS has dropped by -$0.04 (-6.78%).
- DNLI quarterly EPS is now -132.98% below its all-time high of $1.91, reached on December 31, 2020.
Performance
DNLI Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$2.76
+$0.09+3.16%
September 30, 2024
Summary
- As of February 7, 2025, DNLI TTM earnings per share is -$2.76, with the most recent change of +$0.09 (+3.16%) on September 30, 2024.
- Over the past year, DNLI TTM EPS has increased by +$0.09 (+3.16%).
- DNLI TTM EPS is now -1051.72% below its all-time high of $0.29, reached on June 30, 2021.
Performance
DNLI TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
DNLI EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.2% | -6.8% | +3.2% |
| 3 y3 years | -268.3% | +16.0% | -6.2% |
| 5 y5 years | -171.8% | +16.0% | -6.2% |
DNLI EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.2% | -148.5% | +26.7% | -187.5% | +3.8% |
| 5 y | 5-year | -268.3% | +59.2% | -133.0% | +26.7% | -1051.7% | +3.8% |
| alltime | all time | -268.3% | +92.1% | -133.0% | +73.3% | -1051.7% | +25.2% |
Denali Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.63(+6.8%) | -$2.76(-3.2%) |
| Jun 2024 | - | -$0.59(-13.2%) | -$2.85(+196.9%) |
| Mar 2024 | - | -$0.68(-20.9%) | -$0.96(-11.1%) |
| Dec 2023 | -$1.06(-59.2%) | -$0.86(+19.4%) | -$1.08(+11.3%) |
| Sep 2023 | - | -$0.72(-155.4%) | -$0.97(-11.0%) |
| Jun 2023 | - | $1.30(-262.5%) | -$1.09(-62.0%) |
| Mar 2023 | - | -$0.80(+6.7%) | -$2.87(+10.4%) |
| Dec 2022 | -$2.60(+8.8%) | -$0.75(-10.7%) | -$2.60(+5.3%) |
| Sep 2022 | - | -$0.84(+75.0%) | -$2.47(+6.5%) |
| Jun 2022 | - | -$0.48(-9.4%) | -$2.32(-0.9%) |
| Mar 2022 | - | -$0.53(-14.5%) | -$2.34(-2.1%) |
| Dec 2021 | -$2.39(-479.4%) | -$0.62(-10.1%) | -$2.39(-1807.1%) |
| Sep 2021 | - | -$0.69(+38.0%) | $0.14(-51.7%) |
| Jun 2021 | - | -$0.50(-13.8%) | $0.29(+26.1%) |
| Mar 2021 | - | -$0.58(-130.4%) | $0.23(-11.5%) |
| Dec 2020 | $0.63 | $1.91(-453.7%) | $0.26(-111.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$0.54(-3.6%) | -$2.21(+2.8%) |
| Jun 2020 | - | -$0.56(+1.8%) | -$2.15(-2.3%) |
| Mar 2020 | - | -$0.55(-1.8%) | -$2.20(+6.8%) |
| Dec 2019 | -$2.07(+430.8%) | -$0.56(+16.7%) | -$2.06(+190.1%) |
| Sep 2019 | - | -$0.48(-21.3%) | -$0.71(+16.4%) |
| Jun 2019 | - | -$0.61(+48.8%) | -$0.61(+3.4%) |
| Mar 2019 | - | -$0.41(-151.9%) | -$0.59(+34.1%) |
| Dec 2018 | -$0.39(-93.4%) | $0.79(-307.9%) | -$0.44(-77.7%) |
| Sep 2018 | - | -$0.38(-35.6%) | -$1.97(+6.2%) |
| Jun 2018 | - | -$0.59(+126.9%) | -$1.85(+16.7%) |
| Mar 2018 | - | -$0.26(-64.9%) | -$1.59(-56.9%) |
| Dec 2017 | -$5.89(-56.3%) | -$0.74(+179.2%) | -$3.69(+14.1%) |
| Sep 2017 | - | -$0.27(-18.3%) | -$3.23(+8.9%) |
| Jun 2017 | - | -$0.32(-86.3%) | -$2.97(+12.3%) |
| Mar 2017 | - | -$2.36(+732.2%) | -$2.64(+832.2%) |
| Dec 2016 | -$13.49(+141.8%) | -$0.28 | -$0.28 |
| Dec 2015 | -$5.58 | - | - |
FAQ
- What is Denali Therapeutics annual earnings per share?
- What is the all time high annual EPS for Denali Therapeutics?
- What is Denali Therapeutics annual EPS year-on-year change?
- What is Denali Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Denali Therapeutics?
- What is Denali Therapeutics quarterly EPS year-on-year change?
- What is Denali Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Denali Therapeutics?
- What is Denali Therapeutics TTM EPS year-on-year change?
What is Denali Therapeutics annual earnings per share?
The current annual EPS of DNLI is -$1.06
What is the all time high annual EPS for Denali Therapeutics?
Denali Therapeutics all-time high annual earnings per share is $0.63
What is Denali Therapeutics annual EPS year-on-year change?
Over the past year, DNLI annual earnings per share has changed by +$1.54 (+59.23%)
What is Denali Therapeutics quarterly earnings per share?
The current quarterly EPS of DNLI is -$0.63
What is the all time high quarterly EPS for Denali Therapeutics?
Denali Therapeutics all-time high quarterly earnings per share is $1.91
What is Denali Therapeutics quarterly EPS year-on-year change?
Over the past year, DNLI quarterly earnings per share has changed by -$0.04 (-6.78%)
What is Denali Therapeutics TTM earnings per share?
The current TTM EPS of DNLI is -$2.76
What is the all time high TTM EPS for Denali Therapeutics?
Denali Therapeutics all-time high TTM earnings per share is $0.29
What is Denali Therapeutics TTM EPS year-on-year change?
Over the past year, DNLI TTM earnings per share has changed by +$0.09 (+3.16%)